Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr ...
NEW YORK CITY, NY / ACCESS Newswire / February 7, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...
Atara Biotherapeutics, Inc.’s ATRA share price has surged by 12.53%, which has investors questioning if this is right time to ...
Pomerantz LLP is investigating claims on behalf of investors of Atara Biotherapeutics, Inc. ("Atara" or the "Company") . Such investors are advised to contact Danielle Peyton at ...
As night fell across a remote region of northern Australia, a “velvet” creature emerged from a pile of rocks. Its hard-to-reach habitat and camouflaged coloring helped it go largely unnoticed — until ...
The testbed for the latest and greatest radar under development for the Eurofighter Typhoon is an unusual looking model of ...